4//SEC Filing
Rolfe Lindsey 4
Accession 0000899243-22-030421
CIK 0001466301other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:15 PM ET
Size
9.2 KB
Accession
0000899243-22-030421
Insider Transaction Report
Form 4
Rolfe Lindsey
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-09-01+5,063→ 112,123 total - Exercise/Conversion
Restricted Stock Units
2022-09-01+5,063→ 50,625 total→ Common Stock (5,063 underlying) - Sale
Common Stock
2022-09-02$1.20/sh−2,545$3,054→ 109,578 total
Footnotes (3)
- [F1]Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
Related Parties
1- filerCIK 0001650504
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 4:15 PM ET
- Size
- 9.2 KB